Fotemustine plus dacarbazine for malignant melanoma
FOTEMUSTIN PRI DISSEMINIROVANNOY MELANOME KOZhI
... Dacarbazine and Fotemustine. Cancer Res 1991; 51:619-23. Avril M.F, Bonneterre J, Cupssol D, et al. Fotemustine plus dacarbazine for malignant melanoma. Eur ...
DACARBAZINE CITRATE - Inxight Drugs
Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma. A multicenter phase II study of the Italian ...
Interaction of Dacarbazine and Imexon, In Vitro and In Vivo, in ...
DTIC plus imexon cytotoxicity is additive. Human A375 melanoma cells were treated for 4 days, either simultaneously with DTIC and imexon, or after 1 h pre- ...
MUPHORAN (fotemustine), nitrosourea
alternative to dacarbazine, particularly in the event of brain metastases, in the alternative treatment of advanced stage melanoma. Pre ...
dacarbazine | Cancer Care Ontario
Fotemustine. Fatal Acute ... Bcl-2 Antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the oblimersen melanoma study group.
Melanoma metastatic fotemustine weekly induction therapy (part 1 ...
A phase III study compared fotemustine and dacarbazine (DTIC) in terms of overall response rate (ORR) as primary end-point and overall survival, ...
Recent advances in the treatment of melanoma with BRAF and MEK ...
Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF-mutant metastatic melanoma: a phase 2 double-blind randomised ...
Fotemustine is a nitrosourea alkylating agent used in the treatment of metastatic melanoma. It is available in Europe but has not been approved by the ...
Dacarbazine for Injection, USP
interaction with SH groups. INDICATIONS AND USAGE. Dacarbazine for Injection, USP is indicated in the treatment of metastatic malignant melanoma. In addition, ...